Symphony Clinical Research Revenue and Competitors

Claim your profile

Chicago, IL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Symphony Clinical Research's estimated annual revenue is currently $25.5M per year.(i)
  • Symphony Clinical Research's estimated revenue per employee is $201,000

Employee Data

  • Symphony Clinical Research has 127 Employees.(i)
  • Symphony Clinical Research grew their employee count by -7% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$683.2M275554%$1.8MN/A
#2
$265.3M132019%N/AN/A

Changing the face, changing the place, changing the pace of clinical trials. Symphony Clinical Research integrates clinical trial expertise with in-home care and nursing to bring the site visit to the patient wherever he or she lives, works or plays. To effectively manage each trial in which we participate, our logistical planning experience and processes ensure that the right person is in the right place at the right time with all the support and materials they need, including thorough training in the trial protocol. Our core business is in-home clinical trial services. Our focus is to deliver overall savings in time and costs by increasing patient enrollment while improving retention and compliance.

keywords:N/A

N/A

Total Funding

127

Number of Employees

$25.5M

Revenue (est)

-7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Symphony Clinical Research News

2022-04-19 - Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results

The increase in research and development expenses is due to continued clinical studies and scale-up manufacturing of the Symphony IL-6 Test.

2022-04-17 - Clinical Catch-Up: AACR, AAN and COVID-19

Early data from the ongoing Phase I SYMPHONY trial demonstrated dose-dependent decreases in circulating tumor DNA (EGFR variant allele fractions)...

2022-04-06 - Blueprint Medicines Announces BLU-945 Proof-of-Concept Data Supporting Initiation of Comprehensive Combination Development Strategy in EGFR-mutant Non-Small Cell Lung Cancer

Initiating SYMPHONY trial cohort to evaluate BLU-945 in combination with osimertinib --. -- Clinical trial supply agreement signed with...

2019-09-05 - Around Town: Blessing of the Waves returns to Surf City on ...

The Pacific Amphitheatre will be the site of two Pacific Symphony concerts ... Training the next generation of clinical research leaders through ...

2019-08-19 - PRA Health Sciences Announces Strategic Alliance between ...

The data solutions and insights available through Symphony and ... Since 2000, PRA has participated in more than 3,800 clinical trials.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$65.3M1851%N/A
#2
$30.3M1906%N/A
#3
$37.8M19126%N/A
#4
$53.7M214-4%N/A
#5
$85M21912%N/A